Clinical trial
Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)
NCT01895764 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)
- Lead sponsor
- University Hospital, Tours
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 20, 2013
- Completion date
- April 27, 2015
- Enrollment
- 110 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
ankylosing spondylitis